Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8095
|
pubmed:dateCreated |
1978-12-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
896
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:81442-Female,
pubmed-meshheading:81442-Fetal Diseases,
pubmed-meshheading:81442-Humans,
pubmed-meshheading:81442-Hyperthyroidism,
pubmed-meshheading:81442-Infant, Newborn,
pubmed-meshheading:81442-Male,
pubmed-meshheading:81442-Maternal-Fetal Exchange,
pubmed-meshheading:81442-Pregnancy,
pubmed-meshheading:81442-Propylthiouracil
|
pubmed:year |
1978
|
pubmed:articleTitle |
Maternal propylthiouracil to manage fetal hyperthyroidism.
|
pubmed:publicationType |
Letter,
Case Reports
|